Skip to main content
Caplight Logo









Phil, Inc.

Phil, Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://phil.us/

Last Round

Debt

Jul 8, 2025

Total Funding Raised

$151M

Company Overview

Phil, Inc. is a healthcare technology company that provides an end-to-end digital platform to improve patient access, affordability, and adherence for specialty and retail pharmaceutical brands.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Patient Engagement, Revenue Cycle, Workflow Automation

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

prescription fulfillmentpatient access platformspecialty pharmacyprior authorizationmedication adherencedigital pharmacypharma hub servicesworkflow automationtime-to-therapyB2B2Ccommercialization partnerSaaShealthtechpharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phil, Inc. Comparables

Compare Phil, Inc. with similar companies based on industry and business-model similarity.

Phil, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AssistRx
80%
CareTria
79%
CareMetx
79%

Phil, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 8, 2025
Series DJun 3, 2021
Series CJul 1, 2020
Series BMay 15, 2019
Series AAug 16, 2017

Key People

Founding team and executive leadership

Dave Van Dongen

Co-CEO

Executive Team

Deepak Thomas

Founder CEO

Founding Team

Jonas Boli

Chief Product Officer

Executive Team

Phil, Inc. Investors

Notable investors and investment history

Phil, Inc. investors
InvestorRounds
GreatPoint VenturesSeries B
Uncork CapitalSeries A, Series B
SV AngelSeries A
Tarsadia CapitalSeries B
Forerunner VenturesSeries A
Crosslink CapitalSeries B, Series A
GreatPoint VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 16, 2017

    $10M round led by Crosslink Capital.

Phil, Inc. Filings

Explore SEC and related filing metadata, where available.

Phil, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Phil, Inc.'s valuation, stock price, and market status.

Is Phil a public or private company?

Phil is a private company.

What is the current stock price of Phil?

Phil is a private company with no public stock price. No recent secondary market data is available.

How much is Phil worth (valuation)?

Valuation information for Phil is not publicly available.

Can I buy Phil stock?

Phil shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Phil's last funding round?

Phil's most recent funding round was Debt on July 8, 2025.

Who are the main investors in Phil?

Key investors in Phil include GreatPoint Ventures, Crosslink Capital, GreatPoint Ventures, Warburg Pincus, K2 HealthVentures.

Will Phil IPO soon?

No public IPO plans have been announced for Phil.

How can I track Phil secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phil's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range161
Year Founded2015
Last FundingJul 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?